WASHINGTON DC (April 9, 2019) — The US Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk-factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies.

WASHINGTON DC (April 8, 2019) — Today, the US Food and Drug Administration warned against using test-strips from a previous owner (pre-owned) or test-strips not authorized for sale in the US because they may potentially cause infection or lead to inaccurate test results, which can cause serious harm, including death.

DAVENPORT, IOWA (April 4, 2019) — Gilda’s Club and Genesis Cancer Care Institute are partnering to offer Cancer Transitions™. The workshop begins Tuesday, May 7 (meets for 6 weeks) from 5:30–7:30PM at Gilda’s Club Quad Cities (1234 East River Drive, Davenport, Iowa).

CHICAGO, ILLINOIS (April 2, 2019) — In the wake of an announcement by the Centers for Disease Control and Prevention (CDC) that there have been more cases of Measles in the first three months of 2019 than in all of 2018, the American Medical Association (AMA) today issued the following statement urging individuals to check their immunization status and get vaccinated against the measles if not already immune.